Différences entre versions de « Insuffisance rénale chronique »
De médecine.top
| Ligne 2 : | Ligne 2 : | ||
** Niveau basal de l'eGFR | ** Niveau basal de l'eGFR | ||
** Degré de protéinurie/albuminurie | ** Degré de protéinurie/albuminurie | ||
| + | |||
| + | == Traitement == | ||
| + | The Kidney Disease: Improving Global Outcomes guidelines recommend treatment with a statin in all patients with non-dialysis–dependent chronic kidney disease (CKD) who are over 50 years of age and in adults 18 to 49 years of age with non-dialysis–dependent CKD and any one of the following: coronary disease, diabetes mellitus, prior ischemic stroke, or a >10% estimated risk of coronary death or nonfatal myocardial infarction. | ||
[[Category:Néphrologie]] | [[Category:Néphrologie]] | ||
Version du 16 juin 2020 à 14:47
- Facteurs prédictifs de progression vers l'insuffisance rénale terminale:
- Niveau basal de l'eGFR
- Degré de protéinurie/albuminurie
Traitement
The Kidney Disease: Improving Global Outcomes guidelines recommend treatment with a statin in all patients with non-dialysis–dependent chronic kidney disease (CKD) who are over 50 years of age and in adults 18 to 49 years of age with non-dialysis–dependent CKD and any one of the following: coronary disease, diabetes mellitus, prior ischemic stroke, or a >10% estimated risk of coronary death or nonfatal myocardial infarction.
